Want to see VMD full AI Analyst Report?
Viemed Healthcare (VMD) Stock Statistics & Valuation Metrics
Total Valuation
Viemed Healthcare has a market cap or net worth of $368.31M. The enterprise value is $471.69M.
- Market Cap
- $368.31M
- Enterprise Value
- $471.69M
Share Statistics
Viemed Healthcare has 38,088,226 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 38,088,226
- Owned by Insiders
- 13.93%
- Owned by Institutions
- 24.22%
Financial Efficiency
Viemed Healthcare’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.30%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 8.30%
- Return on Capital Employed (ROCE)
- 0.12
- Revenue Per Employee
- 187.96K
- Profits Per Employee
- 10.39K
- Employee Count
- 1,438
- Asset Turnover
- 1.26
- Inventory Turnover
- 22.75
Valuation Ratios
The current PE Ratio of Viemed Healthcare is 25.03. Viemed Healthcare’s PEG ratio is 4.50.
- PE Ratio
- 25.03
- PS Ratio
- 1.19
- PB Ratio
- 2.51
- Price to FCF
- 12.30
- Price to Operating Cash Flow
- 5.94
- PEG Ratio
- 4.50
Income Statement
In the last 12 months, Viemed Healthcare had revenue of 270.28M and earned 14.93M in profits. Earnings per share was 0.38.
- Revenue
- 270.28M
- Gross Profit
- 155.46M
- Operating Income
- 20.71M
- Pretax Income
- 21.77M
- Net Income
- 14.93M
- EBITDA
- 51.56M
- Earnings Per Share (EPS)
- 0.38
Cash Flow
In the last 12 months, operating cash flow was 60.78M and capital expenditures -31.55M, giving a free cash flow of 29.24M billion.
- Operating Cash Flow
- 60.78M
- Free Cash Flow
- 29.24M
- Free Cash Flow per Share
- 0.76
Dividends & Yields
Viemed Healthcare pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 8.13%
- Earnings Yield
- 4.02%
Stock Price Statistics
- Beta
- 0.50
- 52-Week Price Change
- 46.13%
- 50-Day Moving Average
- 9.23
- 200-Day Moving Average
- 9.61
- Relative Strength Index (RSI)
- 46.50
- Average Volume (3m)
- 325.28K
Important Dates
Viemed Healthcare upcoming earnings date is Nov 04, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 03, 2026
- Next Earnings Date
- Nov 04, 2026
- Ex-Dividend Date
- ―
Financial Position
Viemed Healthcare as a current ratio of 1.18, with Debt / Equity ratio of 11.27%
- Current Ratio
- 1.18
- Quick Ratio
- 1.06
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 0.05
- Interest Coverage Ratio
- 17.52
Taxes
In the past 12 months, Viemed Healthcare has paid 6.39M in taxes.
- Income Tax
- 6.39M
- Effective Tax Rate
- 0.29
Enterprise Valuation
Viemed Healthcare EV to EBITDA ratio is 6.72, with an EV/FCF ratio of 12.33.
- EV to Sales
- 1.20
- EV to EBITDA
- 6.72
- EV to Free Cash Flow
- 12.33
- EV to Operating Cash Flow
- 5.93
Balance Sheet
Viemed Healthcare has $10.68M in cash and marketable securities with $11.60M in debt, giving a net cash position of -$920.00K billion.
- Cash & Marketable Securities
- $10.68M
- Total Debt
- $11.60M
- Net Cash
- -$920.00K
- Net Cash Per Share
- -$0.02
- Tangible Book Value Per Share
- $2.25
Margins
Gross margin is 57.21%, with operating margin of 8.14%, and net profit margin of 4.81%.
- Gross Margin
- 57.21%
- Operating Margin
- 8.14%
- Pretax Margin
- 7.02%
- Net Profit Margin
- 4.81%
- EBITDA Margin
- 17.78%
- EBIT Margin
- 7.75%
Analyst Forecast
The average price target for Viemed Healthcare is $12.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $12.50
- Price Target Upside
- 32.42% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 25.21%
- EPS Growth Forecast
- 6.14%
Scores
- Smart Score
- 8
- AI Score
- 67
